학술논문

A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis
Document Type
Letter
Source
In: British Journal of Haematology. (British Journal of Haematology, June 2012, 157(6):766-769)
Subject
Language
English
ISSN
00071048
13652141